Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Europroteome, Harvard Join GEML Consortium

 

NEW YORK, Dec 8 - Rosetta Inpharmatics said Friday Agilent Technologies, Europroteome, and the Harvard University Center for Genomic Research have joined its recently formed GEML consortium, a group that was formed to support the Gene Expression Markup Language format for gene expression and proteomics data as well as annotation.

Members of the group agree to exchange ideas regarding the future of gene expression data interchange and to participate in developing GEML, an open-standard XML file format that converts various gene expression data files into a common format. Members also commit to make their software products GEML-compatible.

“These organizations' membership in the GEML Community supports Rosetta Inpharmatics' goal of fostering collaboration and the sharing of gene expression and proteomics data for life science research," Mark Boguski, senior vice president of research and development at Rosetta, said in a statement.

Rosetta launched GEML in October and is distributing it for free along with a set of gene expression data visualization tools. Spotfire signed on as an initial member of the group.

For more information about the GEML file format and how to use it, go to www.geml.org .

 

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.